Yicura BioMed
Yicura BioMed is a biotech company in Hong Kong, Hong Kong. It has raised $12.0M across 1 round, most recently a $12.0M Series A in July 2023.
Yicura BioMed Limited
- Total Funding
- $12.0M
- Last Round
- $12.0M Series AJul 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Rebranded from Immuno Cure; portfolio company of the Alibaba Entrepreneurs Fund.
Summary
It has raised $12.0M in total across 1 round, most recently a $12.0M Series A round in Jul 2023.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2023
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/yicura-biomed"><img src="https://indexed.vc/api/badge/company/yicura-biomed" alt="Yicura BioMed on Indexed.vc" width="260" height="76" /></a>